Nalaganje...
Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection?
The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has been declared a pandemic by the WHO that claimed the lives of thousands of people within a few months. Cancer patients represent a vulnerable population due to the acquired immunodeficiency associated with anti-cancer therapy. Immu...
Shranjeno v:
| izdano v: | Immunotherapy |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Future Medicine Ltd
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161588/ https://ncbi.nlm.nih.gov/pubmed/32290754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0077 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|